Correlations between p21 expression and clinicopathological findings, p53 gene and protein alterations, and survival in patients with endometrial carcinoma

The Journal of Pathology
K ItoC T Garret

Abstract

The p21 protein inhibits cyclin-dependent kinases and mediates cell-cycle arrest and cell differentiation. It is induced by wild-type p53, but not by mutant p53. This study of 75 patients with endometrial carcinoma investigates the relationship between p21 expression and the functional status of p53, and the usefulness of p21 as a prognostic marker. Correlations were determined between p21 immunoreactivity, p53 overexpression as examined by immunohistochemistry, p53 DNA mutations as examined by polymerase chain reaction-single-stranded conformation polymorphism (PCR-SSCP) analysis, and clinicopathological features, including the clinical outcome. Immunoreactivity for p21 and p53 mutations were detected in 47 (62.7 per cent), 37 (49 per cent), and 23 (31 per cent) patients, respectively. There were no significant correlations between the presence or absence of p21 immunoreactivity and p53 overexpression and DNA mutations. Survival curves revealed that patients with p53 overexpression tended to have a poorer prognosis than those without p53 overexpression (P = 0.104), that patients with p53 mutations had a significantly worse prognosis than those without mutations (P = 0.035), and that patients with p21 expression tended to have ...Continue Reading

Citations

Nov 21, 2007·Urologia Internationalis·Antonio S Salinas-SánchezJulio Escribano-Martínez
Mar 12, 1999·Annual Review of Medicine·J TsihliasJ Slingerland
Apr 18, 2014·Journal of Immunology Research·Massimo PancioneVittorio Colantuoni
Feb 12, 2017·Cancer Science·Kaoru YamawakiTakayuki Enomoto
Jun 24, 2003·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Ozlem ErdemAhmet Erdem
Feb 24, 2001·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·H Yaziji, A M Gown
Jul 1, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Y ItoM Monden
Jul 6, 2000·The Journal of Pathology·J L Burton, M Wells
Mar 3, 2007·Obstetrics and Gynecology·Nita Karnik LeeJohn K Chan
Sep 26, 2006·International Journal of Cancer. Journal International Du Cancer·Alok MishraBhudev C Das
Feb 22, 2005·Applied Immunohistochemistry & Molecular Morphology : AIMM·Banu LebeAli Küpelioğlu
Apr 11, 2000·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·M E Sherman
Jun 18, 2003·Journal of Cellular Physiology·Karin Milde-Langosch, Sabine Riethdorf
Oct 3, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G PruneriA Neri
May 20, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H B SalvesenL A Akslen
Nov 1, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Cristina MaccalliFilippo Belardelli
Oct 26, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kiyoshi ItoSatoshi Inoue
Jul 24, 2002·Biochemical and Biophysical Research Communications·Bo ChenDonald G Blair

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.